What are the causes of splenic microabscesses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aetiology of Splenic Microabscesses

Splenic microabscesses develop primarily through two mechanisms: bacteremic seeding of bland splenic infarctions (from embolic occlusion of splenic arteries) or direct seeding by infected emboli, most commonly as a complication of infective endocarditis (IE). 1

Primary Pathogenic Mechanisms

The American Heart Association guidelines clearly delineate that splenic abscess formation in IE occurs via:

  • Bacteremic seeding of bland infarction: Embolic vegetations occlude splenic arteries, creating infarcts that subsequently become infected through hematogenous spread
  • Direct septic embolization: Infected emboli from valvular vegetations directly seed the spleen 1

Approximately 40% of left-sided IE cases develop splenic infarction, but only 5% of these progress to abscess formation 1.

Causative Organisms

In Infective Endocarditis Context

The microbiology reflects the organisms causing IE itself 1:

  • Viridans streptococci: 40% of culture-positive cases
  • Staphylococcus aureus: 40% of culture-positive cases
  • Enterococcus species: 15% of cases (notably E. faecalis is overrepresented in SA-IE patients at 27.7%) 2
  • Aerobic Gram-negative bacilli: 5% of cases
  • Fungi: 5% of cases

In HIV/Immunocompromised Patients

The etiology shifts dramatically in immunocompromised hosts 3:

  • Mycobacterium tuberculosis: Most common cause (14/32 patients in one series)
  • Visceral leishmaniasis: Second most common (7/32 patients)
  • Mycobacterium avium complex: Disseminated infection (5/32 patients)
  • Salmonella species: Bacteremic spread
  • Candida species: Disseminated fungal infection
  • Rhodococcus equi: Rare opportunistic pathogen

In HIV-infected patients with prolonged fever, tuberculosis accounts for 88.3% of splenic microabscesses detected on ultrasound 4, making it the predominant etiology in this population.

Risk Factors and Associated Conditions

Cardiac Risk Factors 2

  • Prosthetic valves (19.4%)
  • Previous IE (13.9%)
  • Large vegetations ≥15mm (36.1%)

Systemic Risk Factors 2, 5

  • Diabetes mellitus (25% in IE-related SA; particularly uncontrolled diabetes)
  • Intravenous drug use (8.4%)
  • Alcohol abuse (13.9%)
  • Liver disease (5.5%)
  • Immunosuppression (chemotherapy, HIV, transplant recipients) 6

Clinical Context and Pitfalls

Critical caveat: Splenic infarction is common in IE (40% of cases) but clinical splenomegaly is NOT a reliable indicator of either infarction or abscess formation 1. Only 5% of splenic infarcts progress to abscess, so the presence of infarction alone should not trigger intervention.

Key distinguishing features suggesting progression from infarct to abscess 1:

  • Persistent or recurrent bacteremia despite appropriate antibiotics
  • Persistent fever beyond expected treatment response
  • Ongoing sepsis signs
  • Persistence or enlargement of splenic defects on serial CT/MRI imaging

The European Society of Cardiology guidelines emphasize that splenic emboli are common but splenic abscesses remain rare complications 7. However, when present, they respond poorly to antibiotics alone and typically require intervention.

In endemic TB regions with HIV patients: The presence of splenic microabscesses on ultrasound is probably sufficient indication to initiate empirical TB treatment prior to obtaining culture confirmation, given the 88.3% likelihood of TB etiology 4.

References

Research

Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.